CDC Website CDC Website

To Join the NPIN community or

You are here

Drug Abuse

The Substance Abuse and HIV Prevention Navigator Program for Racial/Ethnic Minorities Ages 13-24

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Prevention (CSAP), is accepting applications for fiscal year (FY) 2020 for the Substance Abuse and HIV Prevention Navigator Program for Racial/Ethnic Minorities (Short Title: Prevention Navigator).  The purpose of this program is to provide services to those at highest risk for HIV and substance use disorders. The program proposes to use a navigation approach (Community Health Workers, Neighborhood Navigators, and Peer Support Specialists) to expedite services for these populations.

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)

To establish a Data Center to coordinate and analyze single cell and other molecular data sets generated by Single Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and substance use disorder projects and to make the data findable, accessible, interoperable, and reusable (FAIR) to enable secondary analyses by the scientific community.

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization.

PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional)

NIDA is interested in research that addressing research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited.

PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional)

Edith Jickling's picture

NIDA is interested in research that addressing research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited.

Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) for R34 applications seeks to support: (a) pilot and/or feasibility testing of innovative new, revised, or adapted prevention intervention approaches to prevent or delay the initiation and onset of drug and alcohol use, the progression to misuse or problem use or alcohol and other substance use disorder, reduce drinking and driving and deaths related to impaired driving, prevent suicide attempts (nonfatal and fatal), and the drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis among diverse populations and setting

Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention

NPIN admin's picture
This report discusses substitution maintenance to manage opioid dependence and prevent HIV among injecting drug users (IDUs). The report explains the epidemiology, nature, and cost to society of opioid dependence as well as a definition and rationale for substitution therapy. The report lists the following drugs used in substitution therapy: methadone, buprenorphine, levo alpha acetyl methadol (LAAM), dihydrocodeine, and diacetylmorphine and explains how they are used.

Reversing the Tide: Priorities for HIV/AIDS Prevention in Central Asia

NPIN admin's picture
This report discusses interventions to control the HIV epidemic in Central Asia at national and regional levels. It explains that four different epidemics exist in Central Asia: drug use, STDs, HIV, and TB, and that these increase the vulnerability of countries in Central Asia to an HIV/AIDS crisis over the next twenty years. The report examines critical gaps that need to be addressed.

Sexual Transmission of Hepatitis C Virus Among HIV-Infected Men Who Have Sex With Men – New York City, 2005-2010

NPIN admin's picture
This article reports on a matched case-control study and viral analysis that examined the role of sexual transmission of Hepatics C virus (HCV) among HIV-infected men who have sex with men. In all, 22 case-patients and 53 control subjects were enrolled in the study. Participants completed self-administered questionnaires regarding sexual practices and drug-use behaviors during the 12 months preceding diagnosis or preceding the questionnaire.

Pages

Subscribe to RSS - Drug Abuse